Is the tolerance to the bronchoprotective effect of salmeterol clinically relevant?

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 1, 1998, Pages 1-3

  Nathan, R A ^a   Cockcroft, D W ^a   Drotar, D ^a   Davis, E E ^a  

^a Asthma & Allergy Associates PC and Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; METHACHOLINE; PLACEBO; SALMETEROL;

ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CATARACT; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EDITORIAL; FORCED EXPIRATORY VOLUME; GLAUCOMA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0031933396     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)62929-8     Document Type: Editorial

References (38)

1. Publication No. 97–4051 A. Guidelines for the diagnosis and management of asthma. NIH May 1997.
2. RC Ahrens AC Bonham GA Maxwell MW Weinberger A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine Am Rev Respir Dis 129 1984 903 906
3. J Britton SP Hanley HV Garrett Dose-related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma Thorax 43 1988 300 305
4. DS Pearlman P Chervinsky C LaForce A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma N Engl J Med 327 1992 1420 1425
5. GE D'Alonzo RA Nathan S Henochowicz Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma JAMA 271 1994 1412 1416
6. P Faurschou AM Engel OC Haanaes Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies Allergy 49 1994 827 832
7. SJ Pollard SL Spector SW Yancey Salmeterol versus theophylline in the treatment of asthma Ann Allergy Asthma Immunol 78 1997 457 464
8. G Russell DAJ Williams P Weller JF Price Salmeterol xinafoate in children on high dose inhaled steroids Ann Allergy Asthma Immunol 75 1995 423 428
9. AP Greening PW Ind M Northfield G Shaw Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid Lancet 344 1994 219 224
10. A Woolcock BO Lundback N Ringdal LA Jacques Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids Am J Respir Crit Care Med 153 1996 1481 1488
11. JBD Palmer AM Stuart GL Shepherd K Viskum Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease, a 3 month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms) Respir Med 86 1992 409 417
12. BO Lundback DW Rawlinson JBD Palmer A 12-month comparison of salmeterol with salbutamol as dry powder formulations in asthmatic patients Thorax 48 1993 148 153
13. EY Derom RA Pauwels ME Van Der Straeten The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours J Allergy Clin Immunol 89 1992 811 815
14. HC Campos-Gongora AF Wisniewski AE Tattersfield A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects Am Rev Respir Dis 144 1991 626 629
15. OP Twentyman JP Finnerty A Harris Protection against allergen-induced asthma by salmeterol Lancet 336 1990 1338 1342
16. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma N Engl J Med 327 1992 1198 1203
17. R Bhagat S Kalra VA Swystun DW Cockcroft Rapid onset of tolerance to the bronchoprotective effective of salmeterol Chest 108 1995 1235 1239
18. S Kalra VA Swystun R Bhagat DW Cockcroft Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol Chest 109 1996 953 956
19. L Ramage BJ Lipworth CG Ingram Reduced protection against exercise-induced bronchoconstriction after chronic dosing with salmeterol Respir Med 88 1994 363 368
20. FER Simons TV Gerstner MS Cheang M Math Tolerance to the bronchoprotective effect of salmeterol in adolescents with exericse-induced asthma using concurrent inhaled glucocorticoid treatment Pediatrics 99 1997 655 659
21. DE Drotar EE Davis DW Cockcroft Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice-daily treatment Ann Allergy Asthma Immunol 79 1997 31 34
22. J Kemp C Kalberg W Anderson Effect of 24-week salmeterol therapy on hyperresponsiveness [abstract] Am J Respir Crit Care Med 155 pt2of2pts 1997 A344.
23. Rosenthal R, Chervinsky P, DeGraff A, et al., Long-term, regular treatment with salmeterol is effective in protecting against bronchial hyperresponsiveness as measured by methacholine challenge in asthmatics. J Allergy Clin Immunol; 99(no 1 pt 3):S323.
24. 2-adrenergic receptor Clin Exp Allergy 25 1995 596 598
25. 2-adrenergic receptor structure Pul Pharmacol 8 1995 1 10
26. 2-agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease Thorax 46 1991 9 14
27. KS Tan A Grove A McLean Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients Am J Respir Crit Care Med 156 1997 28 35
28. 2-agonists in asthma N Engl J Med 327 1992 1204 1208
29. E Garbe J LeLorier JF Boivin S Suissa Inhaled and nasal glucocorticoids and the risk of ocular hypertension or open-angle glaucoma JAMA 277 1997 722 772
30. RG Cumming P Mitchell SR Leeder Use of inhaled corticosteroids and the risk of cataracts N Engl J Med 337 1997 8 14
31. SF Weinstein JJ Murray E Kerwin The effect of adding Serevent to Beclovent versus doubling the dose of Beclovent on pulmonary function in symptomatic asthmatic patients =18 years of age [abstract] Am J Respir Crit Care Med 155 pt 2 of 2pts 1997 A347.
32. MG Britton JS Earnshaw JBD Palmer A 12-month comparison of salmeterol with salbutamol in asthmatic patients Eur Respir J 5 1992 1062 1067
33. RA Nathan JM Seltzer JP Kemp Safety of salmeterol in the maintenance treatment of asthma Ann Allergy Asthma Immunol 74 1995 243 248
34. 2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol 95 1995 641 651
35. AAAI Committee on Drugs Position statement: Safety and appropriate use of salmeterol in the treatment of asthma J Allergy Clin Immunol 98 1996 475 480
36. RD1 Mann K Kubota G Pearce Salmeterol: a study by prescription-event monitoring in a UK cohort of 15,407 patients J Clin Epidemiol 49 1996 247 250
37. 2-agonists in the treatment of asthma? Chest 107 1995 1116 1124
38. W Castle R Fuller J Hall J Palmer Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment Br Med J 306 1993 1034 1037